Advanced Medicine

12/28/2022 | Naiara Tejados, PhD | 5 min read

Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies

12/27/2022 | Brian Mullan | 12 min read

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.

12/22/2022 | Angus Stewart | 4 min read

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

12/21/2022 | Angus Stewart | 7 min read

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

12/13/2022 | Angus Stewart

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

12/07/2022 | Dalip Sethi | 7 min read

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

12/06/2022 | Kevin Clifford | 4 min read

Genetic insights may offer shortcuts along the clinical development pathway, bringing new therapeutics to market faster

12/05/2022 | George Todorov | 17 min read

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

12/02/2022 | Rob Coker | 4 min read

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

11/30/2022 | Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine